Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia
DI Ullman, D Dorn, JA Jones, D Fasciano… - …, 2019 - Wiley Online Library
Aims Myeloid sarcoma (MS) is a rare extramedullary neoplasm composed of immature
myeloid precursor cells thought to be a unique clinical presentation of acute myeloid …
myeloid precursor cells thought to be a unique clinical presentation of acute myeloid …
Outcome of acute myeloid leukemia in children adolescents and young adults treated with an uniform protocol in Casablanca, Morocco
B Housou, S Cherkaoui, M Lamchahab… - Indian Journal of …, 2019 - Springer
Abstract Treatment of acute myeloblastic leukemia in children, adolescents and young
adults (AYA) is a challenge in low-income countries. To evaluate treatment outcomes of …
adults (AYA) is a challenge in low-income countries. To evaluate treatment outcomes of …
Unrelated donor hematopoietic stem cell transplantation for pediatric de novo acute myeloid leukemia with intermediate‐or high‐risk cytogenetics
EG Park, ES Yi, YB Choi, KW Sung… - Pediatric …, 2019 - Wiley Online Library
The role of unrelated donor HSCT for children with de novo AML in CR1 is controversial. We
performed this study to investigate the feasibility of unrelated donor HSCT who initially had …
performed this study to investigate the feasibility of unrelated donor HSCT who initially had …
[PDF][PDF] CHILDREN'S ONCOLOGY GROUP AAML1031
R Aplenc - cdn.clinicaltrials.gov
The Children's Oncology Group has received a Certificate of Confidentiality from the federal
government, which will help us protect the privacy of our research subjects. The Certificate …
government, which will help us protect the privacy of our research subjects. The Certificate …
Les leucémies aiguës myéloïdes pédiatriques.
G Leverger, A Petit… - Médecine Thérapeutique …, 2019 - search.ebscohost.com
English Pediatric acute myeloid leukemia (AML) is a rare disease that affects 65 to 85
children under 15 years of age in France each year. The cytogenetic and molecular …
children under 15 years of age in France each year. The cytogenetic and molecular …
Pediatric acute myeloid leukemia
G Leverger, A Petit, H Lapillonne - Médecine thérapeutique/Pédiatrie, 2019 - jle.com
Les leucémies aigües myéloïdes pédiatriques (LAM) sont des maladies rares qui touchent
annuellement en France 65 à 85 enfants de moins de 15 ans. Les caractéristiques …
annuellement en France 65 à 85 enfants de moins de 15 ans. Les caractéristiques …